Puma Biotechnology Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Puma Biotechnology Inc.
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
/ 
Frequently asked questions
To buy Puma Biotechnology Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Puma Biotechnology Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Puma Biotechnology Inc. is PBYI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Puma Biotechnology Inc. has its primary listing on NASDAQ. You can trade Puma Biotechnology Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Puma Biotechnology Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Puma Biotechnology Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Puma Biotechnology Inc..